Stock of The Week | Shark Investing

Stock of the Week – Beyond Air (XAIR)

by siadmin | Nov 21, 2022 | Stock of The Week

Our Stock of the Week is Beyond Air, Inc. (XAIR). XAIR develops nitric oxide delivery systems to treat respiratory and other diseases. This delivery system is much easier and less costly than the traditional systems On June 28, the FDA approved XAIR’s LungFit...

Stock of the Week – Catalyst Pharmaceuticals (CPRX)

by siadmin | Nov 14, 2022 | Stock of The Week

Our Stock of the Week is Catalyst Pharmaceuticals (CPRX). CPRX is a commercial-stage biopharma focused on medicines for rare diseases. In July, the stock increased sharply when Catalyst announced that it settled patent infringement litigation for a Ruzurgi to treat...

Stock of the Week – Quest Resource Holding Corporation (QRHC)

by siadmin | Nov 7, 2022 | Stock of The Week

Our Stock of the Week is Quest Resource Holding, Corp (QRHC). QRHC is a waste and recycling company that helps customers meet business efficiency, sustainability, and ESG goals. It serves large national customers like John Deer, Kroger, Buffalo Wild Wings, etc. The...

Stock of the Week – Inmode, Ltd (INMD)

by siadmin | Oct 31, 2022 | Stock of The Week

Our Stock of the Week is Inmode, Ltd (INMD). InMode is a leading global provider of innovative medical technologies. It develops, manufactures, and markets devices that harness novel radio frequency (“RF”) technology. The InMode system uses light, laser,...

Stock of the Week – Harmony Biosciences Holding (HRMY)

by siadmin | Oct 24, 2022 | Stock of The Week

Our Stock of the Week is Harmony Biosciences Holding (HRMY). HRMY is a commercial-stage pharmaceutical company focused on developing and commercializing drugs for neurological disorder therapies. The company obtained approval for WAKIX in August 2019, which is...

Stock of the Week – AlloVir (ALVR)

by siadmin | Oct 10, 2022 | Stock of The Week

Our Stock of the Week is AlloVir (ALVR). ALVR describes itself as the global leader in developing virus-specific T cell (VST) therapies to treat life-threatening viral diseases. Recently an analyst at Piper stated that he believes the company is on track to announce...